Literature DB >> 6885160

Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin.

J C Paton, A Ferrante.   

Abstract

The in vitro effects of pneumolysin, a sulfhydryl-activated toxin produced by Streptococcus pneumoniae, on various functions of human polymorphonuclear leukocytes (PMNLs) was investigated. Treatment of PMNLs with highly purified toxin significantly inhibited respiratory burst (in response to stimulation), ability to kill opsonized pneumococci, chemotaxis, and random migration. These inhibitions were observed at very low toxin doses (less than or equal to 1 hemolytic unit (2 ng) per 10(6) PMNLs), which had no effect on PMNL viability. These results suggest that pneumolysin could function in pathogenicity by interfering with the ability of PMNLs to migrate toward and kill pneumococci.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6885160      PMCID: PMC264628          DOI: 10.1128/iai.41.3.1212-1216.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes.

Authors:  R D Nelson; P G Quie; R L Simmons
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Effect of immunization with pneumolysin on survival time of mice challenged with Streptococcus pneumoniae.

Authors:  J C Paton; R A Lock; D J Hansman
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

3.  Separation of mononuclear and polymorphonuclear leucocytes from human blood by the one-step Hypaque-Ficoll method is dependent on blood column height.

Authors:  A Ferrante; Y H Thong
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

Review 4.  The microbicidal mechanisms of human neutrophils and eosinophils.

Authors:  R K Root; M S Cohen
Journal:  Rev Infect Dis       Date:  1981 May-Jun

5.  Binding of cholesterol by sulfhydryl-activated cytolysins.

Authors:  M K Johnson; C Geoffroy; J E Alouf
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

6.  Activation of human neutrophil metabolism by streptolysin O.

Authors:  B R Andersen; J L Duncan
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

7.  Effects of pneumolysin on human polymorphonuclear leukocytes and platelets.

Authors:  M K Johnson; D Boese-Marrazzo; W A Pierce
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

8.  Early decay of human neutrophil chemotactic responsiveness following isolation from peripheral blood.

Authors:  A Ferrante; L J Beard; Y H Thong
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

9.  Improved method for neutrophil hexose-monophosphate shunt assay using serum.

Authors:  Y H Thong; V O Rencis
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

Review 10.  The host response to invasion by Streptococcus pneumoniae: protection and the pathogenesis to tissue damage.

Authors:  R B Johnston
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr
View more
  76 in total

1.  An Arcanobacterium (Actinomyces) pyogenes mutant deficient in production of the pore-forming cytolysin pyolysin has reduced virulence.

Authors:  B H Jost; J G Songer; S J Billington
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

2.  Effect on polymorphonuclear cell function of a human-specific cytotoxin, intermedilysin, expressed by Streptococcus intermedius.

Authors:  M G Macey; R A Whiley; L Miller; H Nagamune
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

3.  Induction of gamma interferon and nitric oxide by truncated pneumolysin that lacks pore-forming activity.

Authors:  Hisashi Baba; Ikuo Kawamura; Chikara Kohda; Takamasa Nomura; Yutaka Ito; Terumi Kimoto; Isao Watanabe; Satoshi Ichiyama; Masao Mitsuyama
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

4.  CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection.

Authors:  Aras Kadioglu; William Coward; M Joseph Colston; Colin R A Hewitt; Peter W Andrew
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

5.  Host cellular immune response to pneumococcal lung infection in mice.

Authors:  A Kadioglu; N A Gingles; K Grattan; A Kerr; T J Mitchell; P W Andrew
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

6.  Contributions to protection from Streptococcus pneumoniae infection using the monovalent recombinant protein vaccine candidates PcpA, PhtD, and PlyD1 in an infant murine model during challenge.

Authors:  David Verhoeven; Sheldon Perry; Michael E Pichichero
Journal:  Clin Vaccine Immunol       Date:  2014-05-21

7.  Molecular basis of virulence.

Authors:  T J Mitchell
Journal:  Arch Dis Child       Date:  1998-03       Impact factor: 3.791

8.  Neutralizing monoclonal antibodies against listeriolysin: mapping of epitopes involved in pore formation.

Authors:  A Darji; K Niebuhr; M Hense; J Wehland; T Chakraborty; S Weiss
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

9.  Inhibition of in vitro human lymphocyte response by the pneumococcal toxin pneumolysin.

Authors:  A Ferrante; B Rowan-Kelly; J C Paton
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

10.  Human neutrophils require activation by mononuclear leucocyte conditioned medium to kill the pathogenic free-living amoeba, Naegleria fowleri.

Authors:  A Ferrante; T J Mocatta
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.